Analyst Comments After Endo International (ENDP) Announces to Sell Back Rights to Its Opioid Pain Drug

Specialty pharmaceuticals company Endo International plc (NASDAQ: ENDP) receives a Hold rating this morning from Oppenheimer analyst Derek Archila. The stock has opened today at $15.18 a share. Today morning, the company More »

Brean Capital Reiterates a Buy Rating on PTC Inc

In a report released today, Yun Kim from Brean Capital reiterated a Buy rating on PTC Inc (NASDAQ: PTC). The company’s shares opened today at $48.10, close to its 52-week high of More »